Publications

Skip to content

Publications

Explore Flatiron-authored research

Analysis of real-world progression and insufficient response variables and related endpoints among patients with non-Hodgkin lymphoma

Advances in Therapy

Richey M, Fullerton C, Zhang Q, et al

March 2025

publication-summary-analysis-of-real-world-progression-with-insufficient-response-variables-and-related-endpoints-among-patients-with-non-hodgkin-lymphoma

2,000 publications—and counting

To date, over 2,000 publications—authored by either Flatiron or our partners—have used Flatiron’s real-world data

Explore a list of all publications

See the impact of our data

Database Characterization Guide

An overview of Flatiron Health EHR-derived US data for journal reviewers and readers to better understand the data used in publications

Review our guide

Explore our summaries of Flatiron-authored research

Disease area

Acute myeloid leukemia

Breast cancer

Chronic lymphocytic leukemia

Colorectal cancer

Diffuse large B-Cell lymphoma

Gastric/Esophageal cancer

Head and neck cancer

Hepatocellular carcinoma

Melanoma

Metastatic breast cancer

Multiple myeloma

Non-small cell lung cancer

Ovarian cancer

Pancreatic cancer

Prostate cancer

Renal cell carcinoma

Small cell lung cancer

Tumor agnostic

Urothelial cell carcinoma

Topics

Comparative effectiveness

Drug discovery

HTA and market access

Health equity

Label expansion

Machine learning

Methodology

Prospective study

Quality improvement

Quality reporting

Regulatory

Resistance ID

Treatment patterns

Unmet need

Showing 9 of 0 results

ISPOR
April 2026
Real-world (RW) treatment patterns and outcomes in patients with =2 lines of therapy (LOTS) for recurrent or progressive endometrial cancer
Bhak R, Iyer NN, Hopkins A, et al.
ISPOR
April 2026
From real-world data (RWD) to digital twins: building models for patient-level counterfactual prediction in oncology
Griffith S, Manfredonia J, Ricottone M, et al.
ISPOR
April 2026
Assessing quality of a LLM-derived prostate cancer (PC) real-world dataset: an application of the validation of accuracy for LLM/ML-extracted information and data (VALID) framework
Ward PJ, Qian Y, Hankinson EA, Dolor A, Estevez M, et al.
ISPOR
April 2026
Customization of a large language model approach to capture PSA and imaging derived real-world progression events in prostate cancer
Magee K, Ward P, Chen W, Hankinson E, Dolor A, et al.
ISPOR
April 2026
Evaluating model performance for between-country survival transportability
Ali MS, Pittell H, Horne E, Mpofu P, Zhang Q, Adamson B, et al.
ISPOR
April 2026
External control arm feasibility across external data sources in oncology: methodological and regulatory science considerations
Navarro B, Abdilleh K, Alabaster A, et al.
SGO Annual Meeting
April 2026
Assessing the cumulative effect of high-risk factors for disease progression and death on real-world progression-free survival (rwPFS) in patients with advanced ovarian cancer (aOC)
Chase DM, Lim JT, Golembesky AK, et al.
JSMO Annual Meeting
March 2026
Japanese language EHR LLM extraction of longitudinal unstructured ECOG performance status
Adamson B, Zhang Y, Chamby A, et al.
JSMO Annual Meeting
March 2026
Real-world clinical characteristics and treatment patterns in patients with colorectal cancer (CRC) in Japan
Bando H, Ng D, Nasu I, Tajima E, Adamson B.

Reimagining the infrastructure of cancer care

Resources
Publications
Company
Media
Careers
Contact Us

Real-World Evidence
Point of Care

Legal, Privacy, and Compliance
Cookie Settings
© FLATIRON HEALTH® 2026